Activation of p38MAPK Contributes to Expanded Polyglutamine-Induced Cytotoxicity

• Maria Tsirigotis ,

  Contributed equally to this work with: Maria Tsirigotis, R. Mitchell Baldwin

  Affiliation Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada

  ⨯
• R. Mitchell Baldwin ,

  Contributed equally to this work with: Maria Tsirigotis, R. Mitchell Baldwin

  Affiliations Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Matthew Y. Tang,

  Affiliations Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Ian A. J. Lorimer,

  Affiliations Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Douglas A. Gray

  * E-mail: dgray@ohri.ca

  Affiliations Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯